Oxygen‐insensitive nitroreductase E. coli NfsA, but not NfsB, is inhibited by fumarate. Issue 5 (13th December 2022)

• Record Type: Journal Article
• Authors: Day, Martin A.; Jarrom, David; Rajah, Navina; Searle, Peter F.; Hyde, Eva I.; White, Scott A.
• Is Part Of: Proteins. Volume 91:Issue 5(2023)
• Page Start: 585
• Page End: 592
• Publication Date: 2022-12-13
• Subjects: flavoprotein -- FMN -- fumarate -- nitrofuran -- Nitroreductase -- prodrug; Proteins -- Periodicals; Proteins -- Periodicals; 572.6
• DOI: 10.1002/prot.26451
• Languages: English
• ISSNs: 0887-3585

Abstract

Abstract: Escherichia coli NfsA and NfsB are founding members of two flavoprotein families that catalyze the oxygen‐insensitive reduction of nitroaromatics and quinones by NAD(P)H. This reduction is required for the activity of nitrofuran antibiotics and the enzymes have also been proposed for use with nitroaromatic prodrugs in cancer gene therapy and biocatalysis, but the roles of the proteins in vivo in bacteria are not known. NfsA is NADPH‐specific whereas NfsB can also use NADH. The crystal structures of E. coli NfsA and NfsB and several analogs have been determined previously. In our crystal trials, we unexpectedly observed NfsA bound to fumarate. We here present the X‐ray structure of the E. coli NfsA‐fumarate complex and show that fumarate acts as a weak inhibitor of NfsA but not of NfsB. The structural basis of this differential inhibition is conserved in the two protein families and occurs at fumarate concentrations found in vivo, so impacting the efficacy of these proteins.